HEALTHPEAK PROPERTIES INC (DOC) Stock Fundamental Analysis
USA - NYSE:DOC - US42250P1030 - REIT
17.82 USD
+0.26 (+1.48%)
17.973 USD
+0.15 (+0.86%)
Taking everything into account, DOC scores 3 out of 10 in our fundamental rating. DOC was compared to 127 industry peers in the Diversified REITs industry. DOC has a medium profitability rating, but doesn't score so well on its financial health evaluation. DOC is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
DOC had positive earnings in the past year.
DOC had a positive operating cash flow in the past year.
DOC had positive earnings in each of the past 5 years.
DOC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
DOC has a Return On Assets (0.83%) which is comparable to the rest of the industry.
DOC has a Return On Equity (2.07%) which is comparable to the rest of the industry.
DOC's Return On Invested Capital of 2.07% is on the low side compared to the rest of the industry. DOC is outperformed by 60.63% of its industry peers.
The Average Return On Invested Capital over the past 3 years for DOC is in line with the industry average of 3.07%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 2.07% | ||
| ROIC | 2.07% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
1.3 Margins
The Profit Margin of DOC (5.87%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of DOC has grown nicely.
The Operating Margin of DOC (17.78%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of DOC has declined.
Looking at the Gross Margin, with a value of 60.51%, DOC is doing worse than 64.57% of the companies in the same industry.
In the last couple of years the Gross Margin of DOC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.78% | ||
| PM (TTM) | 5.87% | ||
| GM | 60.51% |
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DOC is destroying value.
DOC has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, DOC has more shares outstanding
Compared to 1 year ago, DOC has about the same debt to assets ratio.
2.2 Solvency
DOC has an Altman-Z score of 0.41. This is a bad value and indicates that DOC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.41, DOC perfoms like the industry average, outperforming 45.67% of the companies in the same industry.
DOC has a debt to FCF ratio of 17.80. This is a negative value and a sign of low solvency as DOC would need 17.80 years to pay back of all of its debts.
DOC's Debt to FCF ratio of 17.80 is fine compared to the rest of the industry. DOC outperforms 77.17% of its industry peers.
DOC has a Debt/Equity ratio of 1.14. This is a high value indicating a heavy dependency on external financing.
DOC has a Debt to Equity ratio (1.14) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 17.8 | ||
| Altman-Z | 0.41 |
ROIC/WACC0.33
WACC6.35%
2.3 Liquidity
DOC has a Current Ratio of 0.19. This is a bad value and indicates that DOC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of DOC (0.19) is worse than 92.91% of its industry peers.
A Quick Ratio of 0.19 indicates that DOC may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.19, DOC is doing worse than 92.13% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.19 | ||
| Quick Ratio | 0.19 |
3. Growth
3.1 Past
DOC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.45%.
The Earnings Per Share has been growing by 28.47% on average over the past years. This is a very strong growth
Looking at the last year, DOC shows a quite strong growth in Revenue. The Revenue has grown by 9.58% in the last year.
DOC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.84% yearly.
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
3.2 Future
Based on estimates for the next years, DOC will show a decrease in Earnings Per Share. The EPS will decrease by -2.84% on average per year.
The Revenue is expected to grow by 5.35% on average over the next years.
EPS Next Y-35.79%
EPS Next 2Y-11.73%
EPS Next 3Y-8.14%
EPS Next 5Y-2.84%
Revenue Next Year3.41%
Revenue Next 2Y3.36%
Revenue Next 3Y3.56%
Revenue Next 5Y5.35%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 89.10, DOC can be considered very expensive at the moment.
The rest of the industry has a similar Price/Earnings ratio as DOC.
DOC's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.83.
A Price/Forward Earnings ratio of 65.35 indicates a quite expensive valuation of DOC.
The rest of the industry has a similar Price/Forward Earnings ratio as DOC.
DOC is valuated expensively when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 89.1 | ||
| Fwd PE | 65.35 |
4.2 Price Multiples
DOC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. DOC is cheaper than 61.42% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DOC indicates a somewhat cheap valuation: DOC is cheaper than 74.02% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.38 | ||
| EV/EBITDA | 13.34 |
4.3 Compensation for Growth
A cheap valuation may be justified as DOC's earnings are expected to decrease with -8.14% in the coming years.
PEG (NY)N/A
PEG (5Y)3.13
EPS Next 2Y-11.73%
EPS Next 3Y-8.14%
5. Dividend
5.1 Amount
DOC has a Yearly Dividend Yield of 6.95%, which is a nice return.
Compared to an average industry Dividend Yield of 6.21, DOC pays a bit more dividend than its industry peers.
DOC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.95% |
5.2 History
The dividend of DOC decreases each year by -2.74%.
DOC has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-2.74%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
515.26% of the earnings are spent on dividend by DOC. This is not a sustainable payout ratio.
DOC's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP515.26%
EPS Next 2Y-11.73%
EPS Next 3Y-8.14%
17.82
+0.26 (+1.48%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners96.35%
Inst Owner Change5.77%
Ins Owners0.22%
Ins Owner Change1.1%
Market Cap12.38B
Revenue(TTM)2.80B
Net Income(TTM)164.00M
Analysts77.5
Price Target21.23 (19.14%)
Short Float %2.26%
Short Ratio1.97
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.95% |
Yearly Dividend1.28
Dividend Growth(5Y)-2.74%
DP515.26%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.51%
Min EPS beat(2)-19.41%
Max EPS beat(2)12.38%
EPS beat(4)2
Avg EPS beat(4)-2.54%
Min EPS beat(4)-79.16%
Max EPS beat(4)76.02%
EPS beat(8)5
Avg EPS beat(8)13.23%
EPS beat(12)7
Avg EPS beat(12)53.56%
EPS beat(16)10
Avg EPS beat(16)40.84%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.37%
Max Revenue beat(2)2.05%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.37%
Max Revenue beat(4)2.05%
Revenue beat(8)6
Avg Revenue beat(8)1.97%
Revenue beat(12)7
Avg Revenue beat(12)-4.86%
Revenue beat(16)11
Avg Revenue beat(16)-3.43%
PT rev (1m)-1.56%
PT rev (3m)-6.61%
EPS NQ rev (1m)3.21%
EPS NQ rev (3m)-8.53%
EPS NY rev (1m)-4.3%
EPS NY rev (3m)-10.1%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-0.52%
Revenue NY rev (1m)-0.07%
Revenue NY rev (3m)-0.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 89.1 | ||
| Fwd PE | 65.35 | ||
| P/S | 4.43 | ||
| P/FCF | 24.38 | ||
| P/OCF | 9.95 | ||
| P/B | 1.56 | ||
| P/tB | 1.71 | ||
| EV/EBITDA | 13.34 |
EPS(TTM)0.2
EY1.12%
EPS(NY)0.27
Fwd EY1.53%
FCF(TTM)0.73
FCFY4.1%
OCF(TTM)1.79
OCFY10.05%
SpS4.02
BVpS11.41
TBVpS10.43
PEG (NY)N/A
PEG (5Y)3.13
Graham Number7.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.83% | ||
| ROE | 2.07% | ||
| ROCE | 2.62% | ||
| ROIC | 2.07% | ||
| ROICexc | 2.08% | ||
| ROICexgc | 2.27% | ||
| OM | 17.78% | ||
| PM (TTM) | 5.87% | ||
| GM | 60.51% | ||
| FCFM | 18.17% |
ROA(3y)2.1%
ROA(5y)2.44%
ROE(3y)5.05%
ROE(5y)5.78%
ROIC(3y)2.19%
ROIC(5y)1.92%
ROICexc(3y)2.2%
ROICexc(5y)1.94%
ROICexgc(3y)2.39%
ROICexgc(5y)2.1%
ROCE(3y)2.77%
ROCE(5y)2.44%
ROICexgc growth 3Y3.4%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y2.73%
ROICexc growth 5Y2.33%
OM growth 3Y-2.63%
OM growth 5Y-7.45%
PM growth 3Y-30.28%
PM growth 5Y20.4%
GM growth 3Y0.52%
GM growth 5Y-2.11%
F-Score6
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.14 | ||
| Debt/FCF | 17.8 | ||
| Debt/EBITDA | 5.7 | ||
| Cap/Depr | 67.65% | ||
| Cap/Sales | 26.35% | ||
| Interest Coverage | 1.93 | ||
| Cash Conversion | 78.47% | ||
| Profit Quality | 309.77% | ||
| Current Ratio | 0.19 | ||
| Quick Ratio | 0.19 | ||
| Altman-Z | 0.41 |
F-Score6
WACC6.35%
ROIC/WACC0.33
Cap/Depr(3y)101.04%
Cap/Depr(5y)178.11%
Cap/Sales(3y)35.69%
Cap/Sales(5y)67.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.45%
EPS 3Y-16.9%
EPS 5Y28.47%
EPS Q2Q%-33.33%
EPS Next Y-35.79%
EPS Next 2Y-11.73%
EPS Next 3Y-8.14%
EPS Next 5Y-2.84%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y12.51%
Revenue growth 5Y16.84%
Sales Q2Q%0.78%
Revenue Next Year3.41%
Revenue Next 2Y3.36%
Revenue Next 3Y3.56%
Revenue Next 5Y5.35%
EBIT growth 1Y-14.85%
EBIT growth 3Y9.55%
EBIT growth 5Y8.14%
EBIT Next Year233.06%
EBIT Next 3Y53.58%
EBIT Next 5Y32.75%
FCF growth 1Y28322.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.95%
OCF growth 3Y10.42%
OCF growth 5Y4.82%
HEALTHPEAK PROPERTIES INC / DOC FAQ
Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a fundamental rating of 3 / 10 to DOC.
Can you provide the valuation status for HEALTHPEAK PROPERTIES INC?
ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (DOC). This can be considered as Overvalued.
What is the profitability of DOC stock?
HEALTHPEAK PROPERTIES INC (DOC) has a profitability rating of 4 / 10.
Can you provide the financial health for DOC stock?
The financial health rating of HEALTHPEAK PROPERTIES INC (DOC) is 2 / 10.
Can you provide the dividend sustainability for DOC stock?
The dividend rating of HEALTHPEAK PROPERTIES INC (DOC) is 5 / 10 and the dividend payout ratio is 515.26%.